Press Room

Press Room

Hoag First in Southern California to Launch Phase I Clinical Trial to Treat Recurrent Neuroendocrine Cancer

NEWPORT BEACH, Calif. (January 12, 2023) – Hoag Memorial Hospital Presbyterian recently became the first hospital in Southern California and one of only a handful of hospitals in the world to provide patients with access to a clinical trial that is poised to change the face of cancer treatment. Hoag launched a phase 1 clinical … Continued

Read More

Hoag Recognized as Best Hospital for Maternity Care by U.S. News & World Report

NEWPORT BEACH, Calif., December 7, 2022 — Hoag Memorial Hospital Presbyterian has been recognized as high performing in maternity care (uncomplicated pregnancy) by U.S. News & World Report. The distinction puts Hoag in the top 10% in the nation to achieve high-performance rankings in 19 specialty procedures and conditions recognized by U.S. News & World … Continued

Read More

First SyncAR for Spine Surgery in the World Performed at Hoag

NEWPORT BEACH, Calif., December 7, 2022 — Hoag’s innovative spine team has performed the first spinal fusion surgery utilizing the recently FDA-cleared augmented reality (SyncAR) surgical navigator for Spine, co-developed by neurosurgeons from Hoag’s Pickup Family Neurosciences Institute and medical visualization platform leader Surgical Theater. SyncAR for Spine utilizes 3D virtual reconstructions of CT and … Continued

Read More

Hoag is the First Hospital in Orange County to Perform Breakthrough Treatment Option for Patients with Severe COPD/Emphysema

NEWPORT BEACH, Calif., November 29, 2022 — Hoag is the first hospital in Orange County to perform a new lung valve treatment on a patient with severe COPD (chronic obstructive pulmonary disease) and emphysema. The procedure has the potential to benefit a number of patients in Orange County who suffer from major quality of life … Continued

Read More

Hoag Recruits Top Cancer Research Medical Director

NEWPORT BEACH, Calif., November 15, 2022 — Hoag Memorial Hospital Presbyterian has recruited top cancer researcher Carlos Becerra, M.D., to become the Hoag Family Cancer Institute’s Medical Director of Cancer Research. He will provide strategic leadership in advancing the institute’s clinical research program and helm the hospital’s growing number of cancer clinical trials. Dr. Becerra … Continued

Read More

Hoag Welcomes Dr. Catherine Ngo to Head Digestive Health Institute Motility Program

NEWPORT BEACH, Calif., November 14, 2022 — Hoag has recruited board-certified gastroenterologist Catherine Ngo, M.D., to head the Hoag Digestive Health Institute’s Motility Program. Dr. Ngo has built a reputation over the last decade as a compassionate, approachable and thorough physician with a strong background in motility. Gastrointestinal motility refers to the coordinated action of … Continued

Read More

Hoag Selected As Official Healthcare Provider for Groundbreaking Program for Former NFL Players

NEWPORT BEACH, Calif., November 10, 2022 — Hoag Memorial Hospital Presbyterian has been named by the Los Angeles Chargers to serve as the exclusive healthcare provider for eligible Former NFL Players as part of the NFL Dedicated Hospital Network Program (The Program). This first-of-its-kind program features high-quality healthcare providers selected by each NFL team in … Continued

Read More

Hoag Receives Get With The Guidelines® GOLD PLUS Awards for Heart Failure Care

NEWPORT BEACH, Calif., September 29, 2022 — Hoag Memorial Hospital Presbyterian announced today it has received the American Heart Association’s GOLD PLUS Get With The Guidelines® – Heart Failure quality achievement award. The national accolade recognizes Hoag’s Jeffrey M. Carlton Heart & Vascular Institute for its commitment to improving outcomes for patients with heart failure, … Continued

Read More

Hoag Enrolling Patients for Clinical Trial of Promising New Investigational Treatment for Alzheimer’s Disease

NEWPORT BEACH, Calif., September 20, 2022 — Hoag’s Pickup Family Neurosciences Institute is initiating a clinical trial for a promising new investigational treatment for Alzheimer’s disease (AD). The Phase I study will determine the safety and tolerability of a single intravenous (IV) dose and multiple IV doses of ACU193. Hoag is seeking individuals who have … Continued

Read More

Hoag Receives Largest Single Gift in Its History – $106 Million from the Estate of Late Philanthropist Audrey Steele Burnand

IRVINE, Calif. (Sept. 15, 2022) – Hoag Memorial Hospital Presbyterian today announced the largest gift in its nearly 70-year history–$106 million from the estate of Audrey Steele Burnand. Hoag officials said the unprecedented gift will be used to significantly expand the hospital’s world-class health care research and treatment capabilities as it steadily climbs into the … Continued

Read More